Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: Pooled analysis of two 12-month, placebo-controlled, randomized trials
E. A. Stewart, M. P. Diamond, A. R.W. Williams, B. R. Carr, E. R. Myers, R. A. Feldman, W. Elger, C. Mattia-Goldberg, B. M. Schwefel, K. Chwalisz
Dive into the research topics of 'Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: Pooled analysis of two 12-month, placebo-controlled, randomized trials'. Together they form a unique fingerprint.